These suggest the tumor-suppressive role of KMT2D, supported by its association with a gene signature resembling the aggressive Moffitt basal-like subtype and indicating a poorer prognosis compared to the classical subtype [106,107,108]. The gene discussed is KMT2D; the disease is neoplasm.